Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
On May 19, 2025, Regeneron Pharmaceuticals announced it has been named the successful bidder in the bankruptcy auction…
On May 9, 2025, Kodak announced it was readying to open its new $20 million manufacturing facility at…
On May 7, 2025, Howard Hughes Medical Institute Investigator Charles Zuker and members of his Columbia University lab…
On May 5, 2025, Bristol Myers Squibb said it will invest $40 billion in the U.S. over the…
On Apr. 2, 2025, Cunard announced a norovirus outbreak had occurred aboard a luxury cruise ship that struck…
On Mar. 20, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
On Jul. 24, 2024, a team led by researchers at Cornell University announced a study that provides evidence…
On Feb. 19, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Sept. 23, 2021, Tonix Pharmaceuticals announced it had expanded its research collaboration with Columbia University. The research…
On Nov. 17, 2020, the proposed settlements between the federal government and OxyContin maker Purdue Pharma and its…
On Oct. 21, 2020, Purdue Pharma announced that it had entered into an agreement with the U.S. Department…
On Oct. 15, 2020, Tonix Pharmaceuticals announced that the first participant was enrolled in the observational PRECISION study…
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Sept. 15, 2019, Purdue Pharma filed for Chapter 11 bankruptcy and announced that it had reached an…
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
On Jun. 21, 2017, McDonnell Genome Institute announced it had received a $10 million from the National Heart,…
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…